• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Thursday, February 2, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Mads Melbye new Scientific Director at the Danish Cancer Society

Bioengineer by Bioengineer
May 23, 2022
in Cancer
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Mads Melbye will take up the position as Scientific Director at the Danish Cancer Society on 15 June. Mads Melbye is a doctor of medicine, professor of medical epidemiology and internationally recognized for his research, which among other things has made a difference for patients with cancer and HIV. He has published more than 600 scientific articles and has many years of experience as a research leader. At the Danish Cancer Society, Mads Melbye will have the overall leadership of the Danish Cancer Society Research Center, which employs approximately 155 researchers from 27 countries. Research at the Center includes epidemiological and biological research, as well as prevention, personalized medicine and perspectives for cancer survivors.

Professor Mads Melbye

Credit: The Danish Cancer Society

Mads Melbye will take up the position as Scientific Director at the Danish Cancer Society on 15 June. Mads Melbye is a doctor of medicine, professor of medical epidemiology and internationally recognized for his research, which among other things has made a difference for patients with cancer and HIV. He has published more than 600 scientific articles and has many years of experience as a research leader. At the Danish Cancer Society, Mads Melbye will have the overall leadership of the Danish Cancer Society Research Center, which employs approximately 155 researchers from 27 countries. Research at the Center includes epidemiological and biological research, as well as prevention, personalized medicine and perspectives for cancer survivors.

 

CEO of the Danish Cancer Society Jesper Fisker is pleased with the appointment of the new Scientific Director:

 

– Mads Melbye has received great recognition for his research and is a visionary and well-liked leader. I look forward to having him on board. Our cancer research is at a very high level, but a continued development requires a constant focus and effort. I know that Mads Melbye can deliver that, says Jesper Fisker.

 

About Mads Melbye
Mads Melbye obtained his MD degree and later DMSc degree at University of Aarhus, Denmark. He was 1985-86 postdoc at the National Cancer Institute, NIH, USA  After clinical training he became senior investigator at the Danish Cancer Registry and from 1991 state epidemiologist at Statens Serum Institut (SSI), Copenhagen, Denmark. He founded the Department of Epidemiology Research at SSI. In 2004 he became a member of SSI’s Executive Board and in 2012 he established the Danish National Biobank. In the period 2016-2020, Melbye was CEO of Statens Serum Institut. Mads Melbye is professor in clinical epidemiology at University of Copenhagen and recently held a position as professor at the Norwegian University of Science and Technology and as senior advisor to the Norwegian Institute of Public Health. He has over the years had other obligations, e.g. as chair of the scientific and later governing council of the International Agency for Cancer Research (IARC) in Lyon, visiting professor at Stanford University School of Medicine, board member at the UK Biobank and, board member at the Cancer Registry of Norway.

About the Danish Cancer Society and the Danish Cancer Society Research Center
The Danish Cancer Society is Denmark’s largest patient association, and research is an integrated part of the Society’s work. 60 per cent of the funds go to research – among other things, to the Danish Cancer Society Research Center on Strandboulevarden in Copenhagen.



Share12Tweet8Share2ShareShareShare2

Related Posts

Age at cancer diagnosis by breed, weight, sex, and cancer type in a cohort of more than 3,000 dogs: Determining the optimal age to initiate cancer screening in canine patients

Dogs’ average age at cancer diagnosis is associated with size, sex, breed

February 1, 2023
PRISMA flow diagram shows identification, screening, and inclusion of studies

MRI surveillance for postsurgical musculoskeletal soft-tissue sarcomas: AJR systematic review and meta-analysis

February 1, 2023

Oncotarget | Mivavotinib for Relapsed/Refractory B-cell Lymphoma (Updated)

February 1, 2023

$1.1 million Department of Defense grant supports Augusta University research linking prostate cancer and cardiovascular diseases

February 1, 2023

POPULAR NEWS

  • Jean du Terrail, Senior Machine Learning Scientist at Owkin

    Nature Medicine publishes breakthrough Owkin research on the first ever use of federated learning to train deep learning models on multiple hospitals’ histopathology data

    65 shares
    Share 26 Tweet 16
  • First made-in-Singapore antibody-drug conjugate (ADC) approved to enter clinical trials

    58 shares
    Share 23 Tweet 15
  • Metal-free batteries raise hope for more sustainable and economical grids

    41 shares
    Share 16 Tweet 10
  • One-pot reaction creates versatile building block for bioactive molecules

    37 shares
    Share 15 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Near-zero-dispersion soliton and broadband modulational instability Kerr microcombs in anomalous dispersion

Astronomers observe light bending around an isolated white dwarf

Nematodes can help us detect indoor air impurities

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 42 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In